3Revak SD, Cochrane CG, Griffin JH. The binding and cleavage characteristics of human Hageman factor during contact actiwition: a comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen[J]. J Clin Invest, 1977, 59:1167.
4Griffin JH. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor X)[J]. Pro Natl Acad Sci U S A, 1978, 75: 1998-2002.
5Ratnoff OD, Margolius Jr A. Hageman trait: an asymptomatic disorder of blood coagulation[J]. Trans Assoc Am Physicians, 1955, 68: 149.
6Renn6 T, Schmaier AH, Nickel KF, et al. In vivo roles of factor XII[J]. Blood, 2012, 120: 4296-4303.
7Lmmle B, Wuillemin WA, Hnber I, et al. Thromboembolism and bleeding tendency in congenital factor X deficiency--a study on 74 subjects from 14 Swiss families[J]. Thromb Haemost, 1991, 65:117.
8Halbmayer WM, Mannhalter C, Feichtinger C, et al. The prewtlence of factor X]I deficiency in 103 orally anticoagulated outpatients :suffering from recurrent venous and/or arterial thromboembolism [J]. Thromb haemost, 1992, 68: 285.
9Bach J, Endler G, Winkelmann BR, et al. Coagulation factor i (FXH) activity, activated FX, distribution of FXII C46T gene polymorphism and coronary risk[J]. J Thromb Haemost, 2008, 6: 291-296.
10Renn6 T, Pozgajov6 M, Grilner S, et al. Defective thrombus formation in mice lacking coagulation factor XII[J]. J Exp Med , 2005, 202: 271-281.
